Rethinking Dental Pain Management
Removing wisdom teeth is a common procedure, yet the period immediately following surgery presents a recurring dilemma for practitioners. Clinicians must decide whether to prescribe opioids before they know how a specific patient will respond to pain. This guesswork often leads to standardized prescribing practices that do not account for individual biological and behavioral differences. Research from the Harvard School of Dental Medicine suggests that artificial intelligence could bridge this gap by offering data-driven insights into patient needs.
Recent data shows that oral and maxillofacial surgery accounts for over 60 percent of all dental opioid prescriptions in the United States. Many of these procedures represent a patient’s initial experience with prescription narcotics. While these drugs are effective, they are frequently overprescribed. A study of third-molar extractions indicated that only 7 percent of patients required opioids during an uneventful recovery. Furthermore, more than half of the opioids dispensed after dental surgery remain in medicine cabinets, creating a significant risk for misuse or diversion.
Data-Driven Decision Support
Tim Wang, the senior author of the study and chief resident of the Oral and Maxillofacial Surgery program, argues that the current model of just-in-case prescribing is outdated. Because surgeons cannot predict a patient's pain tolerance or genetic response during the pre-operative window, they often err on the side of caution. This approach protects against inadequate pain control but ignores the societal costs of excess medication. The researchers suggest that AI models, integrated directly into electronic health records, could offer a more precise path forward.
Samat Borbiev and Clark Morgan, student authors on the project, note that the volume of clinical, genetic, and social factors affecting pain is too vast for any single provider to assess manually. By aggregating these data points, machine learning tools can identify patterns linked to prolonged opioid use or high risk for overdose. These systems could theoretically provide clinicians with recommendations for the appropriate quantity and duration of a prescription tailored to the individual rather than the procedure code.
Future Clinical Implications
Beyond initial prescribing, the researchers envision AI playing a role in post-discharge monitoring. Once a patient leaves the dental clinic, direct supervision disappears. Models capable of incorporating patient-reported outcomes, medication adherence, and ongoing pain levels could help clinicians adjust management strategies in real time. This feedback loop would shift the focus from a one-size-fits-all methodology to a patient-centered approach that prioritizes safety.
However, the adoption of these tools is not without hurdles. The authors warn that AI is an aid for clinical judgment, not a substitute. Much of the current literature relies on retrospective data, and many models lack external validation across diverse patient populations. Performance varies based on the data used for training, meaning implementation requires rigorous oversight. The ultimate objective remains the same: to refine pain management without compromising patient comfort. As the technology matures, it may allow for individualized care plans that consider the unique needs of every patient.